U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07095517) titled 'Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors' on July 24.
Brief Summary: This research study is an open-label Phase 1 Exploratory/Pilot clinical trial to measure the effects of the incretin mimetic, tirzepatide, on tissue, urine, blood, and microbiome biomarkers associated with colorectal cancer risk and to understand the feasibility of this precision prevention trial approach for a future larger study.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Colorectal Cancer Prevention
Colorectal Adenoma
Intervention:
DRUG: Tirzepatide
Study drug injected subcutaneously once a week
...